JNANA THERAPEUTICS Trademark

Trademark Overview

On Friday, June 25, 2021, a trademark application was filed for JNANA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the JNANA THERAPEUTICS trademark a serial number of 90795540. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, December 7, 2023. This trademark is owned by Jnana Therapeutics Inc.. The JNANA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations that modulate historically undruggable targets across target classes, namely, solute carrier (SLC) metabolite transporters, transcription factors, signaling scaffolds and phosphatases for the treatment of rare, autoimmune and inflammatory diseases and cancer
jnana therapeutics

General Information

Serial Number90795540
Word MarkJNANA THERAPEUTICS
Filing DateFriday, June 25, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, December 7, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations that modulate historically undruggable targets across target classes, namely, solute carrier (SLC) metabolite transporters, transcription factors, signaling scaffolds and phosphatases for the treatment of rare, autoimmune and inflammatory diseases and cancer
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJnana Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameJnana Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Saturday, December 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 7, 2023SOU EXTENSION 2 GRANTED
Thursday, December 7, 2023SOU EXTENSION 2 FILED
Thursday, December 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 1, 2023CORRECTED NOA E-MAILED
Monday, July 31, 2023SOU EXTENSION 1 GRANTED
Thursday, June 29, 2023SOU EXTENSION 1 FILED
Monday, July 31, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, June 29, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, July 19, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 29, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 29, 2023TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, January 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 6, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, October 6, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 6, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, October 6, 2022EXAMINERS AMENDMENT -WRITTEN
Saturday, October 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 31, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 31, 2022NON-FINAL ACTION E-MAILED
Thursday, March 31, 2022NON-FINAL ACTION WRITTEN
Thursday, March 17, 2022ASSIGNED TO EXAMINER
Thursday, September 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 29, 2021NEW APPLICATION ENTERED

Related Keywords

therapeutics jnana scaffolds phosphatases signaling factors transcription treatment rare cancer diseases inflammatory